Pembrolizumab with pemetrexed and platinum chemotherapy for untreated, metastatic, non-squamous non-small-cell lung cancer

  • Technology appraisal guidance
  • TA557
  • Published: 

This guidance has been updated and replaced by NICE technology appraisal guidance 683.